Abstract
IntroductionNatalizumab treatment for relapsing remitting multiple sclerosis (RRMS) is associated with a risk of progressive multifocal leukoencephalopathy (PML) due to reactivation of latent JC virus (JCV). We prospectively screened for...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have